Is obesity a risk factor for vaccine non-responsiveness?
Understanding the link between vaccine immunogenicity and efficacy is currently a major focus in HIV research. Consequently, recent developments in the HIV-1 vaccine field have led to a closer look at immune responses to known efficacious vaccines. We undertook a study to explore clinical predictors...
Main Authors: | Katherine M Young, Clive M Gray, Linda-Gail Bekker |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3859613?pdf=render |
Similar Items
-
Hope for HIV control in southern Africa: The continued quest for a vaccine.
by: Linda-Gail Bekker, et al.
Published: (2017-02-01) -
Can we involve adolescents in HIV vaccine trials - can we afford not to?
by: Linda-Gail Bekker
Published: (2005-05-01) -
OBESITY AS A RISK FACTOR FOR CHRONIC NON-COMMUNICABLE DISEASES
by: O. M. Drapkina, et al.
Published: (2016-06-01) -
Virological Breakthrough: A Risk Factor for Loss to Followup in a Large Community-Based Cohort on Antiretroviral Therapy
by: Catherine Orrell, et al.
Published: (2011-01-01) -
A bizarre battle
by: Linda-Gail Bekker
Published: (2003-07-01)